MicroRNA 4270 (miR-4270)

MicroRNA 4270 (miR-4270) is a short, non-coding RNA molecule from the microRNA family, designated as hsa-mir-4270 in humans. MicroRNAs are endogenous RNAs (about 20–24 nucleotides in length) that post-transcriptionally regulate gene expression by binding to complementary sequences in target messenger RNAs (mRNAs), leading to mRNA degradation or inhibition of translation. miR-4270 has been implicated in the regulation of cellular processes such as cell proliferation, differentiation, and apoptosis by influencing the expression of specific gene targets. Aberrant expression of miR-4270 has been observed in several cancers, including nasopharyngeal carcinoma and hepatocellular carcinoma, suggesting potential roles in tumorigenesis and prognosis; however, no approved therapies or direct drugs currently target miR-4270. Like other microRNAs, miR-4270 contributes to the homeostatic regulation of gene networks and may act as a biomarker in disease contexts, though validation for clinical utility is pending.

Other names

hsa-mir-4270MIR4270

Not a direct pharmacological target; microRNAs may be modulated by experimental nucleic acid-based drugs, but no specific mechanism or approved molecules for miR-4270.